The production of recombinant pharmaceutical proteins in plants is entering a new phase with the recent approval of recombinant glucocerebrosidase produced in carrot cells and the successful production of clinical-grade proteins in diverse plant-based production platforms. In the long journey from concept to product, the field of molecular farming has faced technical and economic hurdles, many reflecting the initially limited productivity of plants compared to established platforms such as mammalian cells. This challenge has been met by innovative research aiming to increase recombinant protein yields and maximize the economic benefits of plants. Research has focused on increasing the intrinsic yield capability of plants by optimizing expression construct design, and also on novel strategies to avoid epigenetic silencing and environmental effects on protein accumulation. In this article, we discuss the diverse approaches that have been used to increase the productivity of plant-based platforms for the production of recombinant pharmaceutical proteins and consider future opportunities to maximize the potential of plants and increase their competitiveness outside niche markets.
MOLECULAR FARMING IN PLANTS
Plants have been used for more than 20 years to produce recombinant human proteins for medical purposes, an approach known as either molecular farming or molecular pharming [1] [2] [3] [4] . The initial proof-of-principle studies raised a great deal of excitement because they demonstrated that plants were suitable for the production of a diverse range of human proteins that were difficult or expensive to produce using other platforms. This began with the initial demonstration that a functional antibody could be produced in tobacco [5] and led to a large number of studies in which plants were used to produce various antibody formats, subunit vaccines, hormones, cytokines, blood products, enzymes and technical reagents [6] .
By the late 1990s there was serious interest in the development of molecular farming as a commercial process, led by the US biotechnology company Prodigene Inc. which initially produced the egg protein avidin on a commercial basis in maize seeds [7] and swiftly followed this with additional products such as -glucuronidase, laccase and trypsin, which were marketed by Sigma-Aldrich Fine Chemicals (SAFC, St Louis, MI). Part of the attraction of plants was that researchers immediately grasped the benefits of exploiting the diversity of plant species and platforms to match the requirements of individual products [8] . In contrast, the traditional industry platforms for recombinant protein production had become standardized to one or a few established species, e.g. Escherichia coli for bacteria, Saccharomyces cerevisiae and Pichia pastoris for yeast, and Chinese hamster ovary (CHO) cells for mammalian cell systems. This restricted the flexibility of each system and made certain products impossible to manufacture economically. Although molecular farming in plants was considered an alternative to the established platforms, it actually encompassed many different types of platforms, including fast-growing leafy crops for rapid largescale production, seed crops for enhanced stability, fruit and vegetable crops for the production of oral vaccines, plant cells for production in containment and many additional variants.
*Address correspondence to this author at the TRM Ltd, PO Box 93, York, YO43 3WE, United Kingdom; E-mail: richard@twymanrm.com Generally, plants were considered favorable because of the low up-front and running costs of cultivation in greenhouses or in the field compared to fermenters, the scalability of plants (particularly in the field) making them suitable for high-volume/low-margin products (commodity proteins) and the enhanced safety profile (particularly in the greenhouse) because plants do not support the replication of human viruses. But despite these advantages, the development of molecular farming as an industry was held back by several factors, including the reliance on fermentation infrastructure within the biopharmaceutical industry and the resistance to disruptive technologies, the lack of regulations for the use of plant systems to manufacture biopharmaceutical products [4, 9] and the low yields that were achieved in plants compared to established platforms.
THE YIELD PROBLEM
The yield problem in molecular farming is best considered by looking at industry expectations. Mammalian cells are currently the gold standard for the production of complex human proteins and this is because the regulatory framework has evolved hand in hand with technical improvements (strain and process optimization) allowing the biopharmaceutical industry to build up a critical mass of knowledge, experience and regulatory familiarity with these cells. As an example, CHO cells were first used in 1987 for the production of tissue plasminogen activator, and over the next 25 years a huge amount of data has accumulated about the properties of the cells, their safety profile and their capabilities. Vast improvements in performance have been achieved during this time so that a yield of 5-10 mg/L is now considered routine. Only 2 years after the advent of CHO cells, tobacco was first shown to produce functional antibodies. However, the comparatively low yields and the alien nature of plant cultivation compared to the existing fermentationbased industry infrastructure meant that tobacco was relegated to a curiosity, at least from the industry perspective. It would take many years for plants to gain a foothold in the industry and only then as niche systems for products with special requirements [4, 10, 11] .
It is also important to consider the yield problem from three different perspectives, i.e. the difference between intrinsic yield, biomass yield and scalability. The intrinsic yield is the amount of recombinant protein that can be produced as a percentage of total soluble protein or (more usefully for direct comparisons across platforms) as a proportion of wet or dry biomass. The intrinsic yield of all plant systems is currently lower than the key fermenter platforms (bacteria, yeast and mammalian cells). However, plants have the capacity to produce much more biomass than a conventional fermenter, particularly when growing in the field. A hectare of tobacco plants can, for example, produce 1-2 tons of leaf biomass per year (more depending on the variety and cropping practices), whereas a 20-L fermenter running continuously might produce 100-150 kg of wet cells. The relative merits of the two systems therefore depend on the relative costs of growing the biomass and extracting the protein from it successfully. The difference in cost between growing 1, 2, 5 or 10 ha of tobacco is minimal compared to the cost of commissioning and building additional fermentation infrastructure, so for large-volume products, particularly those with a small profit margin, plants are likely to be economically preferable even if the intrinsic yields do not match those of CHO cells. The timescale of production is also important. Fermenter systems are not only difficult to scale up in terms of overall capacity, but the process of scaling up also takes a long time (especially if new facilities are required). Transgenic plants also take time to scale up, but transient expression in plants makes it possible to ramp up production by tenfold in a matter of weeks if necessary, thus leafy plants are now regarded as one of the most promising platforms for rapidresponse scenarios, such as the production of vaccines for emerging pandemics or bioterrorist threats [11] .
The yield problem can be broken down into the factors that control protein accumulation in plants and we consider these issues in the remainder of this article. They include genetic factors affecting gene expression (control of transcription and protein synthesis), epigenetic factors affecting gene expression (transgene integration, copy number and silencing), environmental factors such as temperature and light quality, and intrinsic properties of the protein that influence its stability both before and after isolation. Host-specific and platform-specific factors such as the efficiency of gene expression and protein sequestration into storage compartments are often cited as among the most important considerations when choosing an expression strategy in molecular farming but it is doubtful that these can be isolated as unique components, i.e. they probably reflect the combination of genetic, epigenetic and environmental factors in each host and platform that contribute to the yield of each recombinant protein. The combination of ideal genetic, epigenetic and environmental factors is likely to be responsible for the yield improvements that can be achieved by conventional breeding, particularly by introgressing transgenes into high yielding elite varieties as recently described by Hood and colleagues in maize [12] .
GENETIC FACTORS THAT AFFECT YIELDS 3.1. Regulation of Transcription
The expression of recombinant proteins in plants requires an efficient expression cassette, which must include at the very least a promoter that functions in plants, the transgene itself and a polyadenylation signal/terminator. The polyadenylation signal and terminator are required for precise transcriptional termination, thus preventing the formation of aberrant run-on transcripts that are targets for degradation. These components must be functional but they do not generally affect the transcriptional activity of a gene to the same extent as the promoter, although an Arabidopsis thaliana heat-shock gene terminator has recently been shown to increase transgene expression by approximately four-fold [13] . The efficiency of transcription (i.e. the amount of mRNA produced) and the spatiotemporal expression profile are principally controlled by the promoter, so promoter choice is one of the key aspects of achieving high recombinant protein yields in plants.
Under many circumstances, a strong constitutive promoter is suitable because there is no need to target the protein for accumulation in particular plant organs. The advantage of this approach is that many plant viruses have evolved strong constitutive promoters that work in a wide range of plant species, and these can be used in generic expression vectors that are suitable in many different contexts. The most prevalent of these is the Cauliflower mosaic virus 35S promoter [14] which has been reduced to a core 352-bp fragment that is ideal for small, compact expression cassettes [15] . Full activity requires upstream promoter elements, some of which are tissue-specific, which means that constitutive expression is achieved through the additive effects of multiple tissue-specific motifs [16] . The region between nucleotides -90 and -208 is an enhancer, which can increase promoter activity in a linear fashion when up to four copies are present [14] and can also enhance the activity of linked heterologous promoters [17] . The CaMV 35S promoter is more active in dicotyledonous plants than in cereals, and indeed the same promoter can vary in efficiency in different host species even if those species are closely related [18] . A number of comparable virus-derived promoters have been developed, such as the Cestrum yellow leaf curling virus (CmYLCV) promoter developed by Syngenta AG [19] . However, molecular farming in cereals has benefited from the use of endogenous promoters from housekeeping genes as well as promoters from viruses that infect cereal species. The rice actin-1 promoter [20] and the maize ubiquitin-1 promoter [21] are the most widely used, both of which require the first intron of the corresponding gene for full activity (see next section). Some modified dicot promoters do work well in cereals, an example being the pPLEX series of constructs [22] adapted for use in monocots [23] . The original pPLEX vectors were based on regulatory elements from Subterranean clover stunt virus (SCSV) [22] . Modification was achieved by adding either the act-1 or ubi-1 introns discussed above plus GC-rich enhancer sequences from Banana bunchy top virus (BBTV) or Maize streak virus (MSV) [23] .
Regulated promoters are preferred to constitutive promoters if it is beneficial to restrict the recombinant protein to a particular tissue or organ. For example, although constitutive promoters allow the accumulation of recombinant proteins in seeds, the proteins are also expressed in leaves and roots. The use of seed-specific promoters restricts recombinant protein accumulation predominantly but not exclusively to the seeds, but vegetative organs do not generally accumulate detectable levels of the recombinant protein. For molecular farming in cereal and legume crops, where the seeds are harvested and the leaves and other organs discarded, this can result in higher overall yields (by concentrating the target protein in the harvested biomass and avoiding potential negative effects on vegetative growth) and improves the biosafety profile of the plants by reducing the risk of adventitious contact [24] . Cereal storage protein genes have been rich sources of endosperm-specific promoters [25] . Additional promoters have been shown to direct gene expression to the embryo and aleurone cells [26] [27] [28] . The most impressive yields have been achieved with a novel seed-specific promoter from the common bean (Phaseolus vulgaris) which was used to express a single chain antibody in Arabidopsis thaliana. In contrast to the CaMV 35S promoter, which resulted in antibody accumulation to 1% total soluble protein (TSP), the bean arc5-I promoter resulted in antibody levels in excess of 36% TSP in homozygous seeds, and the antibody retained its antigen binding activity and affinity [29] . Analogous systems have been used to restrict recombinant proteins to the edible tissues of fruit and vegetable crops [30] . Like the CaMV 35S promoter, seed-specific promoters can also be enhanced by duplicating enhancer sequences. For example, a 'super -zein promoter' has been created that contains a duplication of the region -444 to -174, making it more active in endosperm tissue [31] .
Inducible promoters are a special class of regulated promoters whose activity is governed by some form of external chemical or physical stimulus. Although in many cases there is an effort to unlink recombinant protein production from environmental effects so that production is not limited e.g. by light or stress [32] , it can also be advantageous to bring production under environmental control.
For example, where the accumulation of a protein would be detrimental to normal plant growth, production can be delayed until harvest as is the case for the tomato hydroxy-3-methylglutaryl CoA reductase 2 (HMGR2) promoter developed by the now defunct CropTech Inc. as the MeGA promoter system (mechanical gene activation). The promoter used in this system is wound-inducible, and gene expression is activated when the harvested tobacco leaves are shredded prior to protein extraction [33] . Another example is the minimal -amylase 3 promoter, which makes the normally constitutive rice actin-1 promoter sensitive to the presence of sugar and is therefore useful for the induction of recombinant protein expression in plant cell cultures [34] . The magnifection transient expression platform discussed below has also been linked to an inducible promoter so that viral replicons are released from an integrated viral cDNA when plants are exposed to ethanol, resulting in yields of up to 4 mg protein per gram leaf biomass in transgenic Nicotiana benthamiana plants [35] .
Control of mRNA Stability and Translation
The benefits of a good promoter can be undone if the resulting mRNA is unstable or translated inefficiently. Gene expression is often enhanced when the construct contains an intron, reflecting a phenomenon known as intron mediated enhancement (IME) which may involve highly-conserved sequences that are enriched at the 5 end of first introns [36] . Many plant expression constructs also include sequences such as the leader sequences from Alfalfa mosaic virus (AMV) RNA-3, Tobacco mosaic virus (TMV) or Tobacco etch virus (TEV), or endogenous gene sequences such as the 5 untranslated region from the chalcone synthase gene [37] [38] [39] which have been shown empirically to increase mRNA stability and/or enhance the efficiency of translation compared to expression constructs that lack them. Such sequences are often regarded as interchangeable but recent research suggests not only that they have host-specific benefits, but also that the promoter-leader pairing has a significant impact on yields, i.e. different leader sequences are more effective with certain promoters [40] . It is also recommended to trim off endogenous UTRs because these can make the hybrid mRNA unstable or reduce the efficiency of protein synthesis. For example, they may contain cryptic AU-rich sequences that behave as splice sites, encourage the formation of secondary structures that block ribosome movement or trigger RNA interference, or contain spurious AUG sites that tie up ribosomes in the translation of short, futile peptides [41] . Cytoplasmic polyadenylation elements at the 3 ends of transcripts can also stimulate translation by controlling early polyadenylation, and thus help to increase yields [42, 43] .
Efficient translation is encouraged if the sequence context around the initiation codon matches the Kozak consensus for plants [44, 45] . For the expression of human proteins in plants it is particularly important to make sure the codon usage in the transgene is optimized for the host, bearing in mind that codon preferences differ between plant species and the ideal sequence in tobacco may not be the same as the ideal sequence in cereals [46, 47] . It is now becoming more commonplace to produce completely synthetic genes designed from first principles based on the desired amino acid sequence, thus avoiding the potential pitfalls of codon preference, mRNA instability, cryptic splice sites and regulatory elements.
EPIGENETIC FACTORS THAT AFFECT YIELDS
One of the most frustrating aspects of molecular farming in transgenic plants is the unpredictability of transgene expression levels and the loss of expression, sometimes after one or two generations. Transgene expression in plants depends on numerous factors, including the position, structure and complexity of the transgenic locus. One of the most important factors is the position effect, which reflects the influence of genomic DNA surrounding the site of transgene integration [48] . Another is the structure of the locus, including the number of transgene copies, their intactness and their relative arrangement, which influences the likelihood of physical interactions and further recombination within the locus (physical instability) and the induction of silencing through DNA methylation and/or the production of aberrant RNA species from the locus [49] . The general approach is therefore to generate a large population of transformants and select those with the highest expression levels for breeding. This hit and miss approach has been necessary for two reasons, i.e. the lack of understanding of the underlying processes that control transgene expression in a genomic context and the inability to control the site of integration. Progress has been made recently on both these fronts.
Transgene Integration and Position-dependent Silencing
When DNA is introduced into plants, the integration process is uncontrolled, resulting in transgene loci that differ in position, copy number and the nature and extent of transgene rearrangements. Specific position effects can result from the influence of local regulatory elements such as enhancers on the transgene, but these are unusual and are restricted to individual lines that can be eliminated from further investigation. Nonspecific position effects are much more prevalent, and these are generated by the surrounding chromatin architecture, either favoring or inhibiting transgene expression, e.g. where the nucleosome structure of repressed heterochromatin spreads into an adjacent transgene [50] . A third type of position effect arises when the transgene integrates into chromatin with a low tolerance for 'invading' DNA with a different sequence context, such as a different GC content, which acts as a trigger for de novo methylation and the formation of heterochromatin [51] . Prokaryotic DNA may be recognized in this manner, since silencing is often associated with the presence of prokaryotic vector backbone DNA, particular binary vector sequences joining T-DNA to genomic DNA [52] .
Transgene Copy Number, Structure and Intactness
Even if a transgene integrates into a favorable region of the genome, at least three aspects of locus structure can influence transgene stability and expression: copy number, intactness and arrangement. The complexity of transgenic loci generated by Agrobacterium-mediated transformation depends on the strain, plant species and explant type, but generally the loci are simpler than those generated by direct transfer methods such as particle bombardment. For example, Cheng et al. [53] transformed wheat explants using both methods and found that about 35% of the Agrobacterium-transformed plants contained a single copy of the transgene, 50% contained 2-3 copies and 15% contained 4-5 copies. In contrast, only 17% of the bombarded plants contained a single copy of the transgene and the maximum copy number was not determined. Similar experiments in barley revealed that all the Agrobacterium-transformed lines contained 1-3 copies of the transgene while 60% of the bombarded lines contained more than eight copies [54] . The structure of these multicopy loci is highly variable. Whereas T-DNA inserts following Agrobacterium-mediated transformation usually comprise single copies or pairs sharing a common border, often accompanied by flanking vector backbone DNA, the structure of post-bombardment loci is variable, comprising single copies, tandem or inverted repeats, concatemers, intact transgenes, truncated and rearranged sequences, and interspersed genomic DNA. The analysis of transgenic cereal plants by fiber-FISH and intact cell FISH has revealed a higher-order level of organization where discrete integration events are interspersed by large fragments of genomic DNA, up to several hundred kilobase pairs in length. This organization, which generates immense (megabase) transgenic loci, appears unique to direct DNA transfer, and could thus reflect the nature of the transformation process itself [55] .
The impact of transgene copy number on expression is difficult to determine but a large body of evidence has now accumulated to suggest there is no direct correlation. There is evidence that increas-ing the transgene copy number by crossing lines containing the same transgene can boost expression [56, 57] . There is also evidence that multiple copies of the same sequence can induce silencing, often cosuppressing homologous endogenous genes if present [58, 59] . With no absolute correlation between copy number and expression, it seems likely that the copy number can facilitate higher expression or silencing depending on other triggers. It has been shown that inverted repeats can form secondary structures that are favored substrates for methylation, and thus it is likely that cisconfiguration DNA-DNA pairing may be involved in such processes. However, transgene silencing can also occur in trans, i.e. silencing interactions may occur between unlinked loci, such as sequential transformation events with homologous transgenes, or where two plant lines carrying homologous transgenes have been crossed [60, 61] . Complex multicopy transgenic loci could generate hairpin dsRNA, for example if two transgenes are present as inverted repeats, or if truncation and/or rearrangements generated small, aberrant dsRNA species [62, 63] . This would suggest that the intactness and arrangement of repeat sequences are more important than the presence of repeats per se. In other cases it has been suggested that the level of transgene expression may be an important factor, with 'runaway expression' generating enough mRNA to saturate the polyadenylation machinery resulting in large amounts of hairpin mRNA that induce potent silencing effects [64] .
Episomal Expression Strategies
Many of the problems caused by transgene integration can be avoided by utilizing expression platforms that do not require transgene integration into the nuclear genome. Extremely high expression levels have been achieved using transient expression platforms based on Agrobacterium and/or plant viruses [65] [66] [67] [68] [69] which involve the expression of transgenes contained on episomal vectors, either the Agrobacterium T-DNA or a plant virus or a hybrid containing components of each.
Agroinfiltration involves the infiltration of living Agrobacterium tumefaciens into the spaces between leaf mesophyll cells by injection or vacuum infiltration, which allows milligram amounts of protein to be produced within a few days or weeks [70] . Although stable Agrobacterium-mediated transformation occurs at very low efficiency, many cells are initially transformed only for the T-DNA to be diluted and degraded. Before this happens, the T-DNA exists transiently in a large number of cells and can be expressed for several days. There are no position effects because the T-DNA remains episomal, although silencing can still be induced by aberrant RNA species. In the model tobacco host Nicotiana benthamiana, the Tomato bushy stunt virus (TBSV) p19 protein can be coexpressed as a suppressor of silencing to increase expression levels even further [71] [72] [73] . Unfortunately, this protein induces the hypersensitive response in more productive tobacco species such as N. tabacum and the benefits of its deployment are lost [74] . Other suppressors such as the p20 protein from Cucumber necrosis virus (CNV) do not induce this response and could be useful in a wider range of species to maximize expression levels [74] .
All known plant viruses are episomal, and several have been developed as expression vectors either for whole proteins or for the display of epitopes [75, 76] . Viral infections are generally systemic, so infected plants carry the virus in all cells and can produce large amounts of recombinant protein [75, 77] . The most popular systems currently are based on Tobacco mosaic virus (TMV), which has been used to produce idiotype-specific scFv antibodies for the treatment of B-cell lymphoma [78] , and Potato virus X (PVX), although the latter is more of an experimental system than a commercial platform. More progress has been made with the development of hybrid TMV/T-DNA platforms that deconstruct the virus and combine the necessary elements with T-DNA in an episomal transient expression vector tailored for high yields. The magnifection strategy, developed by Icon Genetics, renders the systemic spread of the virus unnecessary through the use of A. tumefaciens as a delivery vehicle [79, 80] . The bacterium delivers the viral genome to so many cells that local spreading is sufficient for the entire plant to be infected. Like the infection stage, systemic spread is a limiting function, often one of the primary determinants of host range. Taking the systemic spreading function away from the virus and relying instead on the bacterium to deliver the viral genome to a large number of cells allows the same viral vector to be used in a wide range of plants.
The integration of transgenes into the plastid genome is not strictly an episomal expression strategy because the vector is not a replicon, but this can instead be regarded as an extrachromosomal expression strategy that can yield large amounts of recombinant protein due to the absence of nuclear position effects and homology-dependent silencing. Instead of introducing transgenes into the nuclear genome, they can be targeted to the chloroplast genome using particle bombardment or another physical DNA delivery technique and integration is favored when the transgene is embedded in a chloroplast DNA homology region [81] . The main benefits of the chloroplast system are that there are thousands of chloroplasts in a typical leaf cell, yet only one nucleus -therefore, the number of transgene copies in the cell following plastid transformation and the establishment of homoplasmy is much higher than for nuclear transformation, promising greater product yields. This is enhanced by the absence of epigenetic phenomena such as transgene silencing in the chloroplast genome. Chloroplasts, derived from ancient bacteria, also support operon-based transgenes allowing the expression of multiple proteins from a single transcript. Finally, and perhaps most importantly from the regulatory perspective, chloroplasts are absent from the pollen of most of our food crops, which limits the potential for outcrossing [81] . The two major disadvantages of the chloroplast system are that plastid transformation is technically limited to a relatively small number of crops, among which only tobacco, tomato, soybean and potato are considered mainstream crops for molecular farming, and that plastid proteins are not glycosylated, so this approach is not suitable for the synthesis of glycoproteins [81, 82] .
Mitigating Position Effects and Silencing
Transgenes can be protected from position effects and other silencing triggers either by buffering or site selection. Buffering involves flanking the transgene with matrix attachment regions (MARs) such as the tobacco Rb7 sequences, which block position effects by establishing an independent chromatin domain and can boost expression levels 2-4-fold in individual tobacco BY-2 cells as well as the proportion of cells expressing the transgene [83] . In exceptional cases up to 25-fold [84] and 140-fold [85] improvements have been achieved, but thus far only with marker genes such as gusA.
It is not only possible to eliminate negative position effects but also to harness positive position effects if the transgene can be targeted accurately to a permissive region of the genome. This can be achieved by either homologous recombination or site-specific recombination, although the former is inefficient in most plant species and the latter generally requires a previously-integrated target sequence for the site-specific recombinase. With the exception of the moss Physcomitrella patens, gene targeting by homologous recombination in plants has a low success rate in the region of 10 -6 which means genuine targeting events must be selected from a large background of random integration events [86] . It has been possible to improve the efficiency of selection by incorporating a strong counterselectable marker in rice and maize [87] [88] [89] . Site-specific integration in plants has been achieved with the bacterial Cre-loxP system, in which the recombinase target site loxP is integrated by standard methods allowing the subsequent introduction of transgene cassettes at the stable loxP site [90, 91] . One problem is that this approach merely transfers the challenge from placing the transgene in a permissive region to placing the loxP site in a permissive region, although once achieved the same acceptor line can be used of any number of different transgenes. Targeting efficiencies can also be improved by using engineered zinc-finger endonucleases or transcription activator-like effector nucleases (TALENs) to introduce site-specific double strand breaks in the plant genome, favoring homologous recombination at those sites [92] . The modular nature of zinc-finger transcription factors means that recombinant DNA technology can be used to 'mix and match' these DNAbinding domains to create recombinant proteins with unique sequence specificities [93, 94] .
Avoiding Repetitive Sequences
Although multiple transgenes do not necessarily induce silencing, it is clear that they can mediate silencing in the presence of other triggers, such as hairpin sequences and secondary structures, leading to a demand for promoters that lack such sequences. Natural promoter diversity can be difficult to achieve if multiple promoters with the same properties are unavailable, so under these circumstances it may be beneficial to explore other strategies such as the construction of synthetic or hybrid promoter constructs [95] . Promoters are often patchworks of different cis-acting elements with defined functions, and novel chimeric promoters with bespoke activity can be created by combining elements from two or more promoters, e.g. a modified CaMV 35S promoter containing sequences from two other viruses was more active than the native CaMV 35S promoter in tobacco plants and more active than the maize -zein promoter in maize seeds [96] . The functional elements from different promoters can also be resolved to a consensus sequence [97] or embedded in a synthetic background to generate a series of non-homologous promoters with the same activity [98] . For the coexpression of two transgenes, a bidirectional promoter can be used so that only a single promoter sequence is required. There are many examples of natural bidirectional promoters (e.g. [99, 100] ) but artificial ones can be created by placing outward facing TATA box/initiator sequences flanking the CaMV 35S promoter [101, 102] with or without additional regulatory elements for spatiotemporal control [103] .
FACTORS CONTROLLING PROTEIN STABILITY
The subcellular localization of a protein contributes to its stability, so further yield improvements have been achieved by adding targeting sequences such as a signal peptide to allow secretion (into the medium for plant cells, or to the apoplast in whole plants), a signal peptide plus a KDEL/HDEL tetrapeptide so that secreted proteins are retrieved to the endoplasmic reticulum (ER), or a signal peptide plus a transmembrane domain, so the recombinant protein is concentrated in the membrane fraction [45] .
Comparative targeting experiments have shown that the secretory pathway is more suitable for the folding and assembly of complex multimeric proteins than the cytosol, and is therefore advantageous for the accumulation of these proteins but not necessarily for the accumulation of small and simple polypeptides [104, 105] . The ER provides an oxidizing environment that favors the formation of disulfide bonds and contains an abundance of molecular chaperones, but few proteases [106] . The partial degradation of antibodies expressed in tobacco leaves has been widely reported and the degradation of recombinant proteins in plants is a general phenomenon [106] [107] [108] , but this is much less apparent in the ER than other compartments [109] . Proteins are directed to the secretory pathway using either a heterologous or endogenous signal peptide, located at the N-terminus of the native protein. Such proteins are cotranslationally imported into the ER and are eventually secreted to the apoplast, a supracellular network of interlinked compartments underlying the cell wall. Depending on its size, a protein can be retained in the cell wall matrix or it can leach from the cell. Although the majority of recombinant proteins are generally more stable in the apoplast than the cytosol, they are often even more stable in the ER lumen. Therefore, antibody expression levels can be increased even further (2-10-fold) if the protein is retrieved to the ER using an H/KDEL C-terminal tetrapeptide tag in addition to the signal peptide [110] . Antibodies retrieved in this manner are not modified in the Golgi apparatus, which means they possess high-mannose glycans but not plant-specific xylose and fucose residues (see Ste- Another strategy to increase protein stability involves the expression of recombinant proteins as fusions with stabilizing sequences, such as the elastin-like peptide repeat, which not only increases yields but also provides a convenient purification method known as reverse transition cycling (reversible temperaturedependent precipitation) [113] . A similar approach involves the use of oleosin fusions in oilcrops such as safflower, since oleosin is targeted to oil bodies and can be separated easily from bulk seed biomass, an approach pioneered by the now-defunct Canadian biotechnology company SemBioSys Genetics Inc., which also developed a GMP process for the extraction of safflower-derived insulin. Another related approach involves fusion with the seed storage protein -zein, which results in the assembly of new storage organelles and increases yields by up to 300% [114] . This is being developed as Zera® technology by the Spanish biotechnology company ERA Biotech. Fungal hydrophobins can also be used to purify proteins by surfactant-based aqueous two-phase partitioning [115] . Interestingly, recent experiments with antibodies expressed as fusion proteins with elastin-like peptides (ELPs) showed that the ELPs also had an impact on trafficking, albeit only in seeds. Antibodies expressed in tobacco seeds were secreted to the apoplast when expressed as naked molecules bearing a KDEL tag, but initiated the formation of novel protein bodied that budded directly from the ER when expressed as ELP fusions [116] . Aberrant recombinant protein localization has also been reported in Arabidopsis seeds [117] and in maize it has been suggested that both recombinant and endogenous proteins can accumulate in different compartments as part of the developmental program [118] .
ENVIRONMENTAL EFFECTS ON YIELD
The environment has a profound impact on plant health, growth and productivity, which are linked to primary metabolism including protein synthesis. Commercial molecular farming processes therefore focus on maintaining plants in peak health during the production cycle and imposing environmental conditions that favor protein accumulation. The most important aspects are light, heat, water and nutrition. Nitrogen plays a pivotal role in plant cell metabolism and is directly connected to amino acid and protein synthesis, making it particularly important in the context of molecular farming. Key aspects of nitrogen metabolism in the control of productivity in cultured plant cells are discussed by Schillberg et The impact of environmental factors is platform-dependent. Moss and duckweed bioreactors function best under constant conditions, with the light intensity, temperature and nutrients maintained at optimum levels for biomass accumulation and protein synthesis. In transient expression systems using whole plants, light, heat and humidity are also maintained to favor constant high-level protein synthesis because it is ideal to achieve the accumulation of as much protein in as short a time as possible due to the relatively short pro-duction cycle. In transgenic plants, it is more important to ensure that conditions are established to maintain healthy plants over a longer period, which means taking into account the need to maintain a circadian rhythm to achieve optimal biomass production. Minor fluctuations in light and temperature can be tolerated because the protein continues to accumulate over weeks or months, and healthier plants with a normal circadian cycle produce more biomass [119] . In contrast, minor fluctuations in temperature have a profound effect on tobacco plants used for transient expression. Even a 2°C change away from the optimal temperature reduced the expression of one protein by 25% and another by 15%, which is a remarkable sensitivity given the difficulty of precise temperature control in a greenhouse environment [120] . There may also be competition among the factors that favor recombinant protein yields so the environment may need to be adjusted carefully. For example, Stevens et al. [121] found that transgenic tobacco plants growing at 25°C with high intensity light produced more biomass and more soluble protein than those growing at 15°C in dim light, but that the latter plants produced higher amounts of a recombinant antibody as a percentage of soluble protein, which may or may not balance the loss of biomass depending on the precise conditions.
CONCLUSION
Protein synthesis and accumulation in plants depends on a large number of interacting factors, which means that many innovative strategies have been developed to increase the yields of recombinant proteins. These strategies focus on two areas, i.e. they seek either to boost the synthesis of the protein or inhibit its degradation. Protein synthesis can be increased by optimizing the components of the expression construct to maximize transcription, mRNA stability and translation, or by diminishing the impact of epigenetic phenomena that inhibit gene expression. Transient expression systems, which rely on episomal vectors rather than transgene integration, have been particularly successful in this regard, although they are exquisitely sensitive to minor environmental variations which have a much less significant impact on transgenic plants [120, 121] . Protein stability can be increased by targeting proteins to 'safe' compartments that minimize degradation, although it is necessary to consider the downstream implications of such strategies. Protein targeting also affects the glycan structures added to proteins and the type of extraction and purification steps required to isolate the protein from the plant matrix. Protein stability is often highest in the endoplasmic reticulum, but in bioreactor-type platforms such as plant suspension cells and moss cultures, a lower intrinsic yield can be tolerated because the recovery of secreted proteins from the medium is more efficient (and less expensive) than extraction and separation from the intracellular milieu. Protein stability can also be increased by 'partnering' strategies, such as the expression of fusion proteins with stabilizing sequences, the co-expression of protective proteins or decoys that act as sacrificial substrates for endogenous proteases. The abolition of host protease activity is another active area of research which may become more prevalent in the future when the complex family of proteases expressed in each plant cell have been mapped and characterized (see Schillberg et al. Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Des 2013; 19(31): 5531-42). There also remain numerous unexplored avenues, such as the potential for gene amplification which has allowed the development of ultra-productive mammalian cell lines. Plants have many advantages over mammalian cells and microbes in terms of cost, scalability and safety, and further research to improve their productivity will ensure they become a truly competitive platform in the future.
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